niacinamide has been researched along with Lymphocytopenia in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, no new evidence has been found regarding the effect of niacinamide on lymphopenia in COVID-19 patients." | 5.51 | Efficiency of nicotinamide-based supportive therapy in lymphopenia for patients with ordinary or severe COVID-19: A randomized controlled trial. ( Han, YL; Hu, Q; Ma, Z; Peng, CF; Zhang, QY, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Q | 1 |
| Zhang, QY | 1 |
| Peng, CF | 1 |
| Ma, Z | 1 |
| Han, YL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficiency and Safety of Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19: A Randomized Clinical Trial[NCT04910230] | 24 participants (Actual) | Interventional | 2020-03-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for niacinamide and Lymphocytopenia
| Article | Year |
|---|---|
Efficiency of nicotinamide-based supportive therapy in lymphopenia for patients with ordinary or severe COVID-19: A randomized controlled trial.
Topics: COVID-19; Hospital Mortality; Humans; Lymphopenia; Niacinamide; SARS-CoV-2 | 2022 |